Literature DB >> 7590874

Induction of mucosal immunity in cotton rats to haemagglutinin-esterase glycoprotein of bovine coronavirus by recombinant adenovirus.

M E Baca-Estrada1, X Liang, L A Babiuk, D Yoo.   

Abstract

An effective vaccine against enteric bovine coronavirus (BCV) must be able to induce mucosal immunity. We recently described the construction of recombinant human adenovirus type 5 (hAd5) carrying the BCV haemagglutinin-esterase (HE) gene in the early transcription region 3 of the adenovirus genome. In this study, we examined the induction of systemic and mucosal immune responses to the hAd5 vector carrying the BCV HE gene (AdBcHE) following intranasal or enteric immunization of cotton rats. Regardless of the route of administration, mucosal immunization with AdBcHE induced significant levels of anti-HE IgG antibodies in serum. In addition, following intranasal immunization with AdBcHE, significant levels of anti-HE IgA antibodies were found in lung washes of immunized cotton rats. Furthermore, the specific anti-HE antibodies in sera and mucosal secretions efficiently neutralized BCV infectivity in vitro. T-cell proliferation and cell-mediated cytotoxic responses against the BCV HE were elicited in the spleen of intranasally immunized animals. The results demonstrate that mucosal immunization with AdBcHE is capable of inducing both systemic and mucosal immunity to the BCV HE. These immune responses may be important in protecting animals from BCV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590874      PMCID: PMC1383821     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Combined oral/nasal immunization protects mice from Sendai virus infection.

Authors:  J G Nedrud; X P Liang; N Hague; M E Lamm
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

2.  A field trial to evaluate the efficacy of a combined rotavirus-coronavirus/Escherichia coli vaccine in dairy cattle.

Authors:  D Waltner-Toews; S W Martin; A H Meek; I McMillan; C F Crouch
Journal:  Can J Comp Med       Date:  1985-01

3.  Structural proteins of bovine coronavirus and their intracellular processing.

Authors:  D Deregt; M Sabara; L A Babiuk
Journal:  J Gen Virol       Date:  1987-11       Impact factor: 3.891

4.  The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity.

Authors:  R Vlasak; W Luytjes; J Leider; W Spaan; P Palese
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Bovine coronavirus structural proteins.

Authors:  B King; D A Brian
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

6.  Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species.

Authors:  W Oualikene; P Gonin; M Eloit
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

7.  Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters.

Authors:  J E Morin; M D Lubeck; J E Barton; A J Conley; A R Davis; P P Hung
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Characterization and isolation of structural polypeptides in haemagglutinating encephalomyelitis virus.

Authors:  P E Callebaut; M B Pensaert
Journal:  J Gen Virol       Date:  1980-05       Impact factor: 3.891

9.  Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus.

Authors:  W Luytjes; P J Bredenbeek; A F Noten; M C Horzinek; W J Spaan
Journal:  Virology       Date:  1988-10       Impact factor: 3.616

10.  Monoclonal antibodies to bovine coronavirus: characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins.

Authors:  D Deregt; L A Babiuk
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

View more
  6 in total

1.  Definition of cotton rat immunoglobulins: sigmodon species differ in expression of IgG isotypes and production of respiratory syncytial virus antibody.

Authors:  J E Coe; G A Prince
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

2.  Replication-defective bovine adenovirus type 3 as an expression vector.

Authors:  P S Reddy; N Idamakanti; Y Chen; T Whale; L A Babiuk; M Mehtali; S K Tikoo
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

Review 3.  Viral vectors for veterinary vaccines.

Authors:  M Sheppard
Journal:  Adv Vet Med       Date:  1999

4.  Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3.

Authors:  P S Reddy; N Idamakanti; L N Zakhartchouk; L A Babiuk; M Mehtali; S K Tikoo
Journal:  Virus Res       Date:  2000-09       Impact factor: 3.303

Review 5.  Mucosal immunity and tolerance: relevance to vaccine development.

Authors:  C Czerkinsky; F Anjuere; J R McGhee; A George-Chandy; J Holmgren; M P Kieny; K Fujiyashi; J F Mestecky; V Pierrefite-Carle; C Rask; J B Sun
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

6.  The use of adenoviral vectors in gene therapy and vaccine approaches.

Authors:  Natália Meneses Araújo; Ileana Gabriela Sanchez Rubio; Nicholas Pietro Agulha Toneto; Mirian Galliote Morale; Rodrigo Esaki Tamura
Journal:  Genet Mol Biol       Date:  2022-10-07       Impact factor: 2.087

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.